Clarifying variability of corticomotoneuronal function in kennedy disease

Muscle and Nerve

Volumn 44, Issue 2, 2011, Pages 197-201

  Steve, Vucic ^a,b   Kiernan, Matthew C ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cortical excitability; Corticomotoneuron; Kennedy disease; Triple stimulation technique; Upper motor neuron

Indexed keywords

ACTION POTENTIAL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORTICOMOTONEURONAL FUNCTION; DISEASE SEVERITY; EVOKED MUSCLE RESPONSE; HUMAN; KENNEDY DISEASE; MOTOR CORTEX; NERVE EXCITABILITY; NEUROMUSCULAR FUNCTION; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; AGED, 80 AND OVER; BULBO-SPINAL ATROPHY, X-LINKED; CEREBRAL CORTEX; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; NEURAL CONDUCTION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 79960533645     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22017     Document Type: Article

References (37)

1. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology1968;18:671-680.
2. Gallo JM. CSpinobulbar muscular atrophy (Kennedy disease). In:Eisen A, editor. Clinical neurophysiology of motor neuron diseases:handbook of clinical neurophysiology. Amsterdam: Elsevier; 2004. p209-214.
3. Harding AE, Thomas PK, Baraitser M, Bradbury PG, Morgan-Hughes JA, Ponsford JR. X-linked recessive bulbospinal neuronopathy: areport of ten cases. J Neurol Neurosurg Psychiatry 1982;45:1012-1019.
4. Olney RK, Aminoff MJ, So YT. Clinical and electrodiagnostic featuresof X-linked recessive bulbospinal neuronopathy. Neurology 1991;41:823-828.
5. Hirota N, Eisen A, Weber M. Complex fasciculations and their origin in amyotrophic lateral sclerosis and Kennedy disease. Muscle Nerve 2000;23:1872-1875.
6. Pachatz C, Terracciano C, Desiato MT, Orlacchio A, Mori F, Rocchi C, et al. Upper motor neuron involvement in X-linked recessive bulbospinalmuscular atrophy. Clin Neurophysiol 2007;118:262-268.
7. Attarian S, Vedel JP, Pouget J, Schmied A. Cortical versus spinal dysfunction in amyotrophic lateral sclerosis. Muscle Nerve 2006;33:677-90.
8. Weber M, Eisen A. Assessment of upper and lower motor neurons in Kennedy disease: implications for corticomoto neuronal PSTH studies. Muscle Nerve 1999;22:299-306.
9. Attarian S, Azulay JP, Lardillier D, Verschueren A, Pouget J. Transcranial magnetic stimulation in lower motor neuron diseases. ClinNeurophysiol 2005;116:35-42.
10. Eisen A. Clinical electrophysiology of the upper and lower motor neuronin amyotrophic lateral sclerosis. Sem Neurol 2001;21:141-154.
11. Vucic S, Kiernan MC. Cortical excitability testing distinguishes Kennedydisease from amyotrophic lateral sclerosis. Clin Neurophysiol 2008;119:1088-1096.
12. Kiers L, Cros D, Chiappa KH, Fang J. Variability of motor potentials evoked by transcranial magnetic stimulation. ElectroencephalogrClin Neurophysiol 1993;89:415-423.
13. Magistris MR, Rosler KM, Truffert A, Myers JP. Transcranial stimulation excites virtually all motor neurons supplying the target muscle.A demonstration and a method improving the study of motor evoked potentials. Brain 1998;121:437-450.
14. Magistris MR, Rosler KM, Truffert A, Landis T, Hess CW. A clinicalstudy of motor evoked potentials using a triple stimulation technique. Brain 1999;122:265-279.
15. Komissarow L, Rollnik JD, Bogdanova D, Krampfl K, Khabirov FA, Kossev A, et al. Triple stimulation technique (TST) in amyotrophiclateral sclerosis. Clin Neurophysiol 2004;115:356-360.
16. Attarian S, Verschueren A, Pouget J. Magnetic stimulation including the triple-stimulation technique in amyotrophic lateral sclerosis. MuscleNerve 2007;36:55-61.
17. Kleine BU, Schelhaas HJ, van Elswijk G, de Rijk MC, Stegeman DF, Zwarts MJ. Prospective, blind study of the triple stimulation techniquein the diagnosis of ALS. Amyotroph Lateral Scler 2010;11:67-75.
18. Vucic S, Howells J, Trevillion L, Kiernan MC. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 2006;33:477-86.
19. Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyper excitability is an early feature of motor neuron disease. Brain 2006;129:2436-2446.
20. Vucic S, Kiernan MC. Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007;78:849-152.
21. Vucic S, Nicholson GA, Kiernan MC. Cortical excitability in hereditary motor neurono pathy with pyramidal signs: comparison with ALS. J Neurol Neurosurg Psychiatry 2010;81:97-100.
22. Vucic S, Cheah BC, Kiernan MC. Defining the mechanisms that underlie cortical hyper excitability in amyotrophic lateral sclerosis. Exp Neurol 2009;220:177-182.
23. Vucic S, Cheah BC, Krishnan AV, Burke D, Kiernan MC. The effects of alterations in conditioning stimulus intensity on short intervalintracortical inhibition. Brain Res 2009;1273:39-47.
24. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbarmuscular atrophy. Nature 1991;352:77-79.
25. Medical Research Council. Aid to the examination of the peripheralnervous system. London: HMSO; 1976.
26. Mills KR, Murray NM. Electrical stimulation over the human vertebral column: which neural elements are excited? ElectroencephalogrClin Neurophysiol 1986;63:582-589.
27. de Carvalho M, Swash M. Nerve conduction studies in amyotrophiclateral sclerosis. Muscle Nerve 2000;23:344-352.
28. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. The effect of lorazepamon the motor cortical excitability in man. Exp Brain Res 1996;109:127-135.
29. Ziemann U. TMS and drugs. Clin Neurophysiol 2004;115:1717-1729.
30. Ziemann U. Cortical threshold and excitability measurements. In:Eisen A, editor. Clinical neurophysiology of motor neuron diseases:handbook of clinical neurophysiology. Amsterdam: Elsevier; 2004. p317-335.
31. Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J. Differential effects on motor cortical inhibition induced by blockade ofGABA uptake in humans. J Physiol (Lond) 1999;517:591-597.
32. Chen R, Lozano AM, Ashby P. Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epiduralrecordings. Exp Brain Res 1999;128:539-542.
33. Inghilleri M, Berardelli A, Cruccu G, Manfredi M. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullaryjunction. J Physiol 1993;466:521-534.
34. Connors BW, Malenka RC, Silva LR. Two inhibitory postsynaptic potentials, and GABAA and GABAB receptor-mediated responses inneocortex of rat and cat. J Physiol 1988;406:443-468.
35. Chen R, Cros D, Curra A, Di Lazzaro V, Lefaucheur JP, Magistris MR, et al. The clinical diagnostic utility of transcranial magneticstimulation: report of an IFCN committee. Clin Neurophysiol 2008;119:504-532.
36. Kiers L, Cros D, Chiappa KH, Fang J. Variability of motor potentialsevoked by transcranial magnetic stimulation. ElectroencephalogrClin Neurophysiol 1993;89:415-423.
37. La Spada AR, Fu YH, Sopher BL, Libby RT, Wang X, Li LY, et al. Polyglutamine-expanded ataxin-7 antagonizes CRX function andinduces cone-rod dystrophy in a mouse model of SCA7. Neuron 2001;31: 913-927.